IFF INTERNATIONAL FLAVORS & FRAGRANCES INC
Industrial Organic Chemicals · NYSE · SEC CIK 51253 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY-1.9%
TTM net income YoY144.4%
TTM EPS YoY141.5%
Revenue 3-yr CAGR-7.4%
Net income 3-yr CAGR121.3%
Margins
Gross margin38.9%
Operating margin7.5%
Net margin2.1%
FCF margin5.4%
EBITDA margin14.3%
Returns
ROE1.4%
ROA0.8%
ROIC (approx.)2.8%
Asset turnover0.36x
Leverage & solvency
Liabilities / assets46.5%
Debt / equity0.47x
Current ratio1.87x
Interest coverage3.72x
Cash quality & payout
Operating cash flow / net income5.84x
Accruals ratio-3.7%
Payout ratio209.7%
Capex / revenue6.9%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY2025*2025-12-31 | FY2024*2024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | $10.89B | $11.48B |
| Cost of revenue | $6.95B | $7.36B |
| Gross profit | $3.94B | $4.12B |
| R&D expense | $694.00M | $671.00M |
| SG&A expense | $1.83B | $2.00B |
| Operating income | -$382.00M | $766.00M |
| Interest expense | $229.00M | $305.00M |
| Pretax income | -$412.00M | $308.00M |
| Income tax | -$53.00M | $41.00M |
| Net income | -$361.00M | $263.00M |
| EBITDA | $580.00M | $1.78B |
| EPS (basic) | -1.41 | 1.04 |
| EPS (diluted) | -1.41 | 1.04 |
| Dividends declared per share | 1.60 | 1.60 |
| Weighted avg. shares (diluted) | 256.00M | 256.00M |
| Balance sheet | ||
| Cash & equivalents | $347.00M | $312.00M |
| Receivables | $1.29B | $1.62B |
| Inventory | $1.51B | $2.13B |
| Current assets | $5.59B | $7.97B |
| PP&E, net | $2.69B | $3.74B |
| Goodwill | $8.23B | $9.07B |
| Intangibles | $3.96B | $6.45B |
| Total assets | $25.54B | $28.72B |
| Current liabilities | $3.93B | $4.35B |
| Short-term debt | $1.25B | $1.41B |
| Long-term debt | $4.74B | $7.56B |
| Total debt | $5.99B | $8.98B |
| Total liabilities | $11.35B | $14.85B |
| Shareholders' equity | $14.15B | $13.83B |
| Net debt | $5.64B | $8.66B |
| Shares outstanding | 255.70M | 255.70M |
| Cash flow statement | ||
| Operating cash flow | $850.00M | $1.07B |
| Capital expenditure | $594.00M | $463.00M |
| Free cash flow | $256.00M | $607.00M |
| Investing cash flow | $2.27B | $326.00M |
| Financing cash flow | -$3.09B | -$1.61B |
| Depreciation & amortization | $962.00M | $1.01B |
| Stock-based compensation | $88.00M | $77.00M |
| Dividends paid | $409.00M | $514.00M |
| Share buybacks | $38.00M | $0 |
Free plan shows the latest 2 periods; Pro shows all 18 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.